Dr. Tom McDonnell:

Yes and no - not very specific studies. One of the difficult issues when it comes to Ireland is that because we have a very small number of enormous taxpayers, what happens to corporation tax receipts is extremely volatile. If Apple, Pfizer or - I should not name names - large corporations based in Ireland have a change in their profits based on what happens in China but the IP asset is in Ireland, that can create massive swings in the corporation tax receipts. Pharmaceutical companies would be the area we would look at specifically to do with tariffs as being quite significant.